CE Mark for DeepPath- LYDIA

By |2024-05-29T16:19:42+03:00June 6th, 2022|Categories: Uncategorized|Tags: , |

We are super excited to announce that DeepPath receives CE marking for DeepPath- LYDIA. The system got regulatory clearance as decision support as per IVDD for helping histopathologists detect metastases on Hematoxylin & Eosin stained lymph nodes from patients with breast cancer, colon cancer, lung cancer, and melanoma. We must note that to the best [...]

€4m Pathfinder Grant

By |2024-05-29T16:20:10+03:00May 6th, 2022|Categories: Uncategorized|Tags: , , |

We are happy to announce that DeepPath as part of a consortium consisting of MIDA Biotech B.V. (an Orgenesis Inc. company), Leiden University, and MIRCOD LLC, acquired a €4m Pathfinder grant from European Innovation Council and SMEs Executive Agency (EISMEA) for the development of an Ai-powered platform to democratize autologous IPCS manufacturing! This is a great [...]

Go to Top